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Background: The purpose of this work is to report on the management of endophthalmitis in 
phakic eyes in which the crystalline lens was preserved.
Methods: The current study is a noncomparative consecutive case series of patients who 
  developed culture-proven endophthalmitis and were treated between January 1995 and June 
2009. The study included only phakic patients whose infection was managed without removal of 
the crystalline lens. Using a computerized search of Microbiology Department records, patients 
were identified with phakic lens status and clinically diagnosed endophthalmitis.
Results: A total of 12 phakic eyes from 11 patients met the study criteria. The etiology of 
infection was endogenous (n = 6), postoperative (n = 5), and post-traumatic (n = 1). Pars plana 
vitrectomy and injection of intravitreal antimicrobials was performed in seven eyes (58%), 
and vitreous tap and injection of antimicrobials was performed in five eyes (42%). All eyes 
showed progression of lens opacification after treatment. Overall, nine (75%) achieved visual 
acuity outcomes $20/80, including five of seven (71%) eyes treated with vitrectomy and four 
of five eyes (80%) treated with injection of antibiotics alone. One of seven eyes (14%) treated 
with vitrectomy had a poor visual outcome (defined as ,20/400) compared with one of five 
(20%) eyes treated with intravitreal antimicrobials alone. During follow-up, all 12 eyes had 
progression of lens opacification and five of 12 (42%) eyes underwent cataract surgery with 
posterior chamber intraocular lens placement.
Conclusion: In phakic patients, successful treatment of endophthalmitis can be achieved while 
preserving the uninvolved crystalline lens. Future cataract surgery with posterior chamber 
intraocular lens placement can be accomplished in many of these patients.
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Introduction
Endophthalmitis is characterized by severe intraocular inflammation caused by 
introduction of microorganisms, and is characterized by pain, conjunctival conges-
tion, and reduced vision. Despite appropriate therapeutic intervention, endophthal-
mitis frequently results in severe visual loss. Since cataract surgery was the most 
commonly performed type of ocular surgery, this setting is the most frequent etiol-
ogy in   clinical practice. However, endophthalmitis may also develop in phakic eyes 
through endogenous spread, after trauma, or after other ophthalmic surgery.1–6 In 
phakic patients with endophthalmitis, the crystalline lens is frequently removed in the 
  setting of lenticular abscess, disruption of lens capsule, total lens opacity, or in eyes 
with severe inflammation causing nonclearing fibrin in the anterior chamber.3,7,8 In 
1991, a similar study of 12 patients from our institution reported the management of 
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endophthalmitis while preserving the uninvolved crystalline 
lens.9 In the current more contemporary study, the course of 
infection in phakic eyes with endophthalmitis is reviewed in 
which the crystalline lens was preserved and compared with 
the previous report.
Methods
The study protocol was approved by the institutional 
review board of the University of Miami Leonard School of 
  Medicine, subcommittee for the protection of human subjects. 
Microbiological and clinical records were reviewed for all 
patients treated at Bascom Palmer Eye Institute between 
January 1995 and June 2009. Patients with endophthalmitis 
managed by lensectomy and vitrectomy were excluded.
Intraocular fluid specimens from these patients were 
plated directly on to chocolate agar, 5% sheep blood agar, 
and Sabouraud agar. Chocolate and blood agars were incu-
bated at 35°C for up to 2 weeks. Sabouraud agars were 
incubated at 35°C for 72 hours and then at 25°C for up to 
2 weeks. Colonies suggestive of fungal growth were evalu-
ated by Giemsa, Calcofluor white, and slice culture to detect 
microscopic morphology and characteristic conditions. 
Cultures were   considered positive when there was growth 
of the same organism on two or more solid media at the 
inoculation site, or when the organism grew on one culture 
media and was noted on a stained smear (Gram, Giemsa, or 
Gomori   methenamine silver). Treatment and management 
decisions were made by the individual treating physicians 
without a predefined study protocol. Demographic informa-
tion,   etiology of   infection, causative organism, treatment 
  modalities, pretreatment and post-treatment lens status, visual 
acuity outcome, and   duration of follow-up were evaluated.
Results
Twelve phakic eyes of 11 patients with culture-positive 
endophthalmitis treated without removal of the uninvolved 
crystalline lens were identified. The 11 patients ranged in age 
from 32 to 76 years. Five patients were female and six were 
male. Six patients had involvement of the right eye, four 
had involvement of the left eye, and one had involvement 
of both eyes. Etiology of infection was endogenous in six 
eyes, a post-glaucoma filtering procedure in five eyes, post-
vitrectomy in one eye, and post-traumatic in one eye. Isolates 
included fungi in seven eyes, followed by Gram-positive 
Table 1 Demographic information, etiology of infection, treatment and causative organism in a phakic endophthalmitis series
Patient Gender, 
age (years), 
eye
Category Predisposing  
factor
Anterior  
chamber  
reaction
Vitritis Treatment/intraocular  
therapy
Culture 
result
1 M 58 L Endogenous Foot ulcer 3+ 2+ PPV, ampho, vanc, ceftaz Candida albicans
2 F 64 L Endogenous ICU patient 3+ 3+ PPV, ampho, dex,  
oral fluconazole
Candida albicans
3 F 50 r Endogenous Osteomyelitis, 
indwelling catheter
3+ 3+, infiltrates Ampho, oral fluconazole Candida albicans
4 M 56 r Endogenous Colorectal surgery 3+ 3+ Ampho, intravenous  
fluconazole,  
PPV (after 2 months)
Candida albicans
L Endogenous Colorectal surgery 2+ 2+, infiltrates PPV, ampho, intravenous  
fluconazole
Candida albicans
5 M 43 r Endogenous IVDA 3+ 3+ PPV, ampho, vanc, ceftaz,  
oral fluconazole
Candida albicans
6 M 32 r Trauma Dust blown in eye 3+ 1+ PPV, vori Candida albicans
7 F 72 L Postoperative Status post glaucoma  
filtering surgery
3+ Trace Vanc, ceftaz, dex Moraxella 
species
8 M 50 r Postoperative Status post glaucoma  
filtering surgery
3+ 1+ Gent, intravitreal  
cefazolin
Haemophilus 
influenzae
9 F 62 L Postoperative Status post glaucoma  
filtering surgery
3+ PPV, vanc, ceftaz, dex Staphylococcus 
aureus
10 F 76 r Postoperative Status post glaucoma  
filtering surgery
4+ Gent, vanc, ceftaz, dex Coagulase- 
negative 
Staphylococcus
11 M 71 r Postoperative Status post PPV for  
NCVH
Large  
hypopyon
Vit hemorrhage Vanc, ceftaz, dex Staphylococcus 
epidermidis
Note: Anterior chamber reaction, vitritis and chorioretinitis are as noted by the treating physician. 
Abbreviations:  ICU,  intensive  care  unit;  PPV,  pars  plana  vitrectomy;  vanc,  intravitreal  vancomycin;  gent,  intravitreal  gentamicin;  ceftaz,  intravitreal  ceftazidime;   
ampho, intravitreal amphotericin B; vori, intravitreal voriconazole; dex, intravitreal dexamethasone; NCVH, nonclearing vitreous hemorrhage.
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bacteria in three and Gram-negative bacteria in two eyes 
(Table 1). Seven eyes (58%) were treated with pars plana 
vitrectomy and injection of intravitreal antimicrobials. 
Five eyes (42%) were treated with intravitreal injection of 
  antimicrobials alone (Table 1). After treatment, 12 of 12 eyes 
had progression of lens opacification at last follow-up 
(Table 2). With an average follow-up of 39 months, nine 
of 12 eyes (75%) had visual acuity outcomes $20/80. 
Visual acuity of 20/80 or better was achieved in five of 
seven (71%) eyes treated with vitrectomy and four of five 
(80%) of eyes treated with injection of antimicrobials alone. 
A visual acuity of 20/80 or better was achieved in four of 
six (67%) eyes with endogenous endophthalmitis, four of 
five (80%) eyes with postoperative endophthalmitis, and all 
(1/1) eyes with post-traumatic endophthalmitis. Poor visual 
  acuity of ,20/400 was noted in two (17%) eyes. One of five 
(20%) eyes treated with intraocular antimicrobials alone 
had a visual outcome #20/400 compared with one of seven 
(14%) eyes that underwent vitrectomy. Cataract surgery with 
posterior chamber intraocular lens placement was performed 
in five of 12 (42%) eyes. All cataract surgeries were noted 
to be   without complications, such as capsular rupture and 
excessive postoperative inflammation.
Discussion
Published evidence is limited regarding the management of 
endophthalmitis while preserving the uninvolved crystal-
line lens. The current study, along with the prior case series 
from the same institution, creates the largest experience 
from a single institution on this subject.9 In the current 
study, all patients with endogenous endophthalmitis were 
  culture-positive for Candida albicans. The majority of these 
eyes had a favorable visual outcome (Figure 1). As reported 
in previous studies, Candida is a more common cause than 
molds in patients with endogenous endophthalmitis, and is 
associated with a more favorable visual outcome.1,10 Candida 
is generally less invasive than molds and is usually responsive 
to amphotericin B.11 In this series, intravitreal amphotericin 
was the most common antifungal used.
In the current study, poor visual outcomes occurred 
with equivalent frequency in eyes undergoing vitrectomy 
and in eyes receiving only intraocular antibiotics. Patient 2, 
with endophthalmitis from endogenous C. albicans, was a 
long-term intensive care unit patient in very poor   general 
health. Patient 11 developed endophthalmitis caused 
by Staphylococcus epidermidis after vitrectomy for a 
  nonclearing vitreous hemorrhage. The infection was treated 
with intravitreal antibiotics but without repeat vitrectomy. 
Visual acuity after subsequent cataract extraction improved 
to 20/80.
In the earlier study, we reported that eyes infected with 
virulent organisms, including Staphylococcus aureus and 
Streptococcus spp and treated with intravitreal antibiotics 
alone tended to have worse visual outcomes. Presence of 
virulent organisms in these cases probably accounts for 
poor visual outcome as published in our previous reports 
and underscores the importance of early vitrectomy in these 
cases.12–14
The advantage of retaining the crystalline lens is 
to allow conventional cataract extraction and posterior 
chamber intraocular lens placement at a later date (Figure 2). 
  Placing an intraocular lens is not possible in the presence of 
Table 2 Pretreatment and post-treatment lens status, visual acuity results, and duration of follow-up in phakic endophthalmitis series
Patient Pretreatment  
lens status
Final lens status  
(before CE)
Presenting  
visual acuity
Final  
visual acuity
Follow-up  
(months)
Comment
1 Clear 1+NS 20/30- 20/25 12 Chronic peripheral rD
2 Clear 3+PSC 20/200 NLP 6 recurrent rD
3 Clear 1+NS 20/80 20/20 12
4 Clear 4+NS 20/100 20/100 23 CE at 9 months macular scar
Clear 2+NS 20/50 20/30 23
5 Trace NS 1+NS HM 20/80 51
6 Clear Trace NS 20/30- 20/20 7
7 2+NS 3+NS 20/400 20/25 53 CE after 22 months
8 1+PSC 2+NS, 2+PSC 20/200 20/30 96
9 1+NS 3+NS, 3+PSC LP 20/60 83 CE after 10 months
10 1+NS 2+NS 20/400 20/40–2 73 CE after 12 months
11 1+NS 3+NS, 3+PSC HM 6/200 31 CE after 27 months; macular scar,   
band keratopathy
Note: Lens status is as noted by the treating physician. 
Abbreviations: CE, cataract extraction; NS, nuclear sclerosis; PSC, posterior subcapsular cataract; HM, hand motion; LP, light perception; NLP, no light perception;   
rD, retinal detachment.
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intraocular infection. Another potential advantage of leaving 
the crystalline lens is the relatively increased half-life of 
intraocular administered antibiotics in phakic compared 
with aphakic eyes.15,16 This may reduce the need for repeat 
intraocular injection of antibiotics.
Because this is a retrospective review, the experience 
of the previous report from our center of improved visual 
outcomes in eyes undergoing vitrectomy compared with eyes 
treated without vitrectomy may have influenced treatment 
decisions (Table 3). Patients infected with the most virulent 
organisms were treated with prompt vitrectomy and intravit-
real antibiotics, and the overall rate of good visual outcomes 
was improved compared with the previous report from our 
center. While this series is not large enough to draw statisti-
cally significant conclusions, excellent visual outcomes were 
seen in eyes treated with intravitreal antimicrobials with and 
without vitrectomy.
In the current study, good visual outcomes were 
often achieved in the treatment of endophthalmitis with 
preservation of the uninvolved crystalline lens. Removal of 
uninvolved crystalline lens may not be necessary unless lens 
opacity represents a violation of an intact lens capsule or the 
cloudy lens precludes a pars plana vitrectomy.
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8 months prior to presentation. (A) Slit lamp at presentation. Visual acuity 20/400. 
Culture positive for Moraxella species. (B) Slit lamp 2 months after presentation. 
Patient  treated  with  intravitreal  vancomycin,  ceftazidime,  and  dexamethasone. 
Visual acuity 20/25. (C) Slip lamp 22 months after presentation, 4 months after 
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vitrectomy; VA, visual acuity.
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